Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Concinnity Genetics is transforming the safety of gene therapies by designing novel control mechanisms using its cutting-edge AI platform and synthetic biology expertise. Founded in 2023, the company…

Concinnity Genetics is transforming the safety of gene therapies by designing novel control mechanisms using its cutting-edge AI platform and synthetic biology expertise. Founded in 2023, the company…
Founded: 2023 (University of Edinburgh spinout)
Product: Modular RNA-based control systems for gene and cell therapies
Tech: AI-driven synthetic biology platform
Founders: Jessica Birt (CEO), Dr Matthew Dale (CSO)
Recent funding: £3.0M seed (closed 16 Dec 2024)
Safety and controllability of gene and cell therapies
2021
Biotechnology
£3,000,000
Oversubscribed seed round with participation from Scottish Enterprise, Old College Capital and Maven Capital Partners.
“Eos, Maven Capital Partners, Old College Capital, Scottish Enterprise”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week